A simple and efficient synthetic glycosylation method suitable for use in solid-phase enzymic oligosaccharide synthesis and sitespecific glycosylation of recombinant proteins to produce defined glycoforms is described. This strategy utilizes N-(fl-saccharide) haloacetamides for attaching oligosaccharides specifically to cysteine residues ofproteins in solution to form neoglycoproteins. The alkylation reaction was tested using N-(fl-chitotriose) bromoacetamide and an unprotected synthetic hexapeptide containing a single cysteine residue. The glycosylated product was confirmed by amino acid and hexosamine analyses as well as laser desorption mass spectrometry. Similarly N-(fi-chitotriose) iodoacetamide was covalently linked to non-reduced BSA to produce a defined glycoform of this protein. The specific attachment of chitotriose at the single cysteine residue in non-reduced serum albumin was suggested by Ellman's assay for free thiols. This was verified by amino acid sequencing of a tryptic glycopeptide derived from this neoglycoprotein. Multiple sugar attachment was ac-
INTRODUCTION
Carbohydrates play important roles in many biological events. The structures of oligosaccharides in biological glycoconjugates are as complex and diverse as their functions. A large body of evidence has suggested that glycans can influence conform.tion and stability of proteins, modulate protein functions and alter immunogenicity and circulatory half-life of proteins and cells (Olden et al., 1982; Rademacher et al., 1988; Varki, 1993) . They can also serve as recognition elements for receptors such as those involved in the transport of lysosomal enzymes (Kornfeld, 1992) , the endocytosis of glycoproteins and pathogens (Weiss and Ashwell, 1989; Taylor et al., 1990 ) and the recruitment of leucocytes to sites of inflammation (Brandley et al., 1990; Lasky, 1992) . The discovery of an increasing number of proteins with similar amino acid sequences to known lectins (Drickamer and Taylor, 1993) would suggest the existence of many more as yet undefined biological processes that are mediated by carbohydrates.
Synthetic glycoconjugates are valuable tools for elucidating the various biological roles of oligosaccharides. Neoglycolipids and neoglycoproteins in particular are very useful for identifying carbohydrate-lectin interactions and defining the fine structural requirements of oligosaccharide ligands for lectin recognition (Childs et al., 1989; Larkin et al., 1992; Lee, 1992) . However, other investigations into the role of carbohydrates in glycoproteins are often complicated by the fact that glycoproteins exist as glycoforms and these glycosylation variants of the same complished using fully reduced serum albumin as demonstrated by the formation of two neoglycoproteins using iodoacetamide derivatives of galactose /31-3-N-acetylgalactosamine (Gal, ) and the major xylose/fucose-class plant-type oligosaccharide of horseradish peroxidase. These two neoglycoproteins with an average of 18-21 sugar residues attached were assayed positively for binding to peanut agglutinin and a sugarspecific anti-(horseradish peroxidase) monoclonal antibody YZ1/2.23 respectively. Sialylation of the neoglycoprotein containing Galfi1-3GalNAc was accomplished using a-2,3-sialyltransferase and radiolabelled CMP-N-acetylneuraminic acid. Significantly, glycan attachment using this conjugation method is reversible as demonstrated by the release of oligosaccharides from these two neoglycoproteins using hydrazinolysis. Therefore this method could provide invaluable reagents for many glycobiological studies.
polypeptide chain can exhibit different in vitro or in vivo biochemical, physiological and immunological properties (Parekh, 1991; Varki, 1993) . A major challenge in glycobiology is to obtain pure glycoforms for structural and functional studies. Although synthetic glycosylation strategies are available for producing N-and 0-linked glycopeptides, they cannot be applied to proteins as they require the use of organic solvents. Current methods, including reductive amination (Gray, 1974) , for attaching sugars to proteins usually involve the amino functions of free N-terminus and lysine side chains of the protein (Stowell and Lee, 1980) . Consequently the net charge of the protein is changed dramatically and the sugar is randomly attached, and therefore the linkage between glycan and protein is very different from either N-or 0-linkages. This may be insignificant if the protein is used solely as a medium to present multiple sugar moieties, as is the case in numerous in vitro binding studies. However, if the protein integrity is of importance and needs to be preserved, alternative chemical methods are required.
We have recently described the use of oligosaccharide ,-glycosylamines as intermediates for neoglycoconjugate formation. We have shown that N-acylation of 8J-glycosylamines with heterobifunctional reagents is a simple and efficient derivatization method which, unlike reductive amination, results in oligosaccharide derivatives that retain the closed ring structure and ,-stereochemistry of asparagine-linked glycans (Manger et al., 1992a,b (Bayard and Montreuil, 1974; Takasaki et al., 1982) as well as 0-linked glycans under certain conditions (Patel et al., 1993) , thus making this sugar derivatization process reversible. We have subsequently illustrated several applications for these types of neoglycoconjugates including those synthesized using l-N-glycyl-/3-saccharide derivatives as intermediates (Wong et al., 1993) . In the present paper, we report the formation of N-(/J-saccharide) haloacetamides and their selective coupling to cysteine side chains of reduced and non-reduced serum albumin. The applications of this derivatization scheme in site-specific glycosylation and solid-phase enzymic oligosaccharide synthesis are demonstrated.
EXPERIMENTAL Materials
NN'N"-Triacetylchitotriose was purified by Bio-Gel P4 gelpermeation chromatography from a partial acid hydrolysate of chitin as described previously (Rupley, 1964 (7:4, v/v) and 0.05 % diaminobutane. Amines and hexoses were visualized using ninhydrin and orcinol sprays respectively. H.p.l.c. was performed as described previously (Manger et al., 1992a) , but the types of column and gradient conditions used in the present study are individually described where appropriate. Amino acid and hexosamine analysis using the PicoTag method has been previously described (Zamze et al., 1991) .
Preparation of p8-glycosylamines and N-(fl-saccharide) haloacetamides saccharides and haloacetylation of ,-glycosylamines were performed as previously described (Manger et al., 1992a; Wong et al., 1993 Determination of synthetic glycosylation site on unreduced BSA BSA (10 mg) was allowed to react with a 100-fold molar excess of the N-(fl-chitotriose) iodoacetamide as described above. The mixture was dialysed exhaustively against distilled water at 4°C to remove unbound sugar. Neoglycoprotein was redissolved in 0.8 ml of 0.1 M Tris/HCl, pH 7.0, containing 0.5 M NaCl, 20 mM MnCl2 and 0.5 mM ATP. 14C-labelled galactose was incorporated into this neoglycoprotein substrate using galactosyltransferase (100 ,l) and UDP-[14C]galactose (100 #1) as donor.
This enzyme reaction was evaluated using ovalbumin (chicken egg albumin, Grade VI; Sigma Ltd) as a standard glycoprotein acceptor substrate. Reversed-phase h.p.l.c. on a Vydac C4 column was used to purify radiolabelled neoglycoprotein. Gradient conditions were as follows [solvent A was 0.1 % trifluoroacetic acid (TFA) (Aldrich) in water, solvent B was 0.1 % TFA in acetonitrile]: initial conditions of 95 % solvent A/5 % solvent B were maintained for 10 min, then a linear gradient from 5 to 100% solvent B was applied over 20 min; the flow rate was 1 ml/min and 2 ml fractions were collected. Ultima Gold scintillation fluid (Canberra Packard, Pangbourne, Berks., U.K.) (3 ml) and water (490 ul) were added to 10 portions of the eluate. These samples were counted for radioactivity using a Beckman LS 3801 liquid-scintillation counter. Approx. 31 % of the total radioactivity was recovered in the neoglycoprotein fractions. The radiolabelled neoglycoprotein was reduced and alkylated before digestion with trypsin. The resultant tryptic peptides were separated by reversed-phase h.p.l.c. using the conditions described above. Radiolabelled fractions were further purified by reversed-phase h.p.l.c. using an Aquapore OD-300 microbore (100 mm x 2 mm) column (Applied Biosystems Ltd., Warrington, Cheshire, U.K.). Gradient conditions were as follows (solvent A was 0.1 % TFA in water, solvent B was 0.09 % TFA in 80 % acetonitrile): initial conditions of 90 % solvent A/10 % solvent B were maintained for 5 min, then linear gradients from 10 to 60% solvent B and 60 to 90% solvent B were applied over 70 and 15 min respectively at a flow rate of 150,al/min using a Severn Analytical microbore h.p.l.c. system.
The formation of f8-glycosylamines of neutral and acidic oligo-A single radiolabelled peak was subjected to amino acid se-quencing using an Applied Biosystems 470A automated sequencer.
Alkylation of reduced BSA BSA was reduced in 0.2 M Tris/HCl, pH 8.0, containing 0.1 M dithiothreitol, 6 M guanidium chloride and 1 mM EDTA for 2 h at 25 'C. After reduction, the pH of the protein solution (10 mg/ml) was adjusted to 3 by dropwise addition of acetic acid. Reduced BSA was subsequently separated from the denaturing and reducing agents by dialysis at 4 'C against 0.1 M acetic acid. The dialysate was lyophilized and stored under nitrogen until use. Lyophilized reduced BSA was resuspended in 50 mM (NH4)2CO3, pH 8.1, containing 5 M guanidium chloride and filtered through a 0.45 ,tm pore-diam. filter. Reduced BSA was alkylated as described above. A tenfold molar excess of iodoacetamide derivatives of Manal-6(Manal-3)(Xyl/J1-2)Man,8l-4GlcNAc,61-4(Fucal-3)GlcNAc and Gal,/1-3GalNAc was used to alkylate reduced BSA. Both neoglycoproteins were concentrated and washed with water using a Centricon C30 protein concentrator (Amicon, Danvers, MA, U.S.A.). Neoglycoproteins were lyophilized and then subjected to analysis of amino acid and hexosamine. The number of sugar-attachment sites was determined by quantifying CM-cysteine and hexosamine residues in the samples. Typically 70% of total cysteine residues in reduced BSA were coupled.
Analyses of neoglycoproteins using antibody and lectins E.l.i.s.a.s were used to confirm the integrity of the conjugated sugar structures. Briefly, neoglycoprotein containing Gal/il3GalNAc (1.5 nmol of sugar/ml) was adsorbed on to an e.l.i.s.a. plate (100 ,ul/well). The plate was washed with 10 mM Tris/HCl, pH 7.4, containing 0.15 M NaCl (TBS) and blocked with 20% (w/v) BSA in TBS. Portions (75 ,ul) of serial twofold dilutions of biotinylated lectins at an initial concentration of 10 l,g/ml in 10 mM Hepes, pH 7.5, containing 0.15 M NaCl and 0.1 mM CaCl2 were added to the plate. After incubation for 2 h, the plate was washed with TBS. Streptavidin-biotinylated alkaline phosphatase complex (Boehringer, Mannheim, Germany), to detect bound biotinylated lectins, was added according to the manufacturer's instructions. The plate was finally developed using pnitrophenyl phosphate as substrate at 37 'C for 20 min, and A405 was measured using a Multiskan MCC340 plate reader.
For neoglycoprotein containing ManaI-6(ManaI-3)(Xyl1#l-2)Man,/1-4GlcNAcfl1-4(Fucal-3)GlcNAc, a similar e.l.i.s.a. was performed using serial two-fold dilutions of an anti-(HRP carbohydrate) monoclonal antibody termed YZ1/2.23 (McManus et al., 1988) at an initial concentration of 2.5 ,ug/ml and alkaline phosphatase-conjugated goat anti-rat immunoglobulin (Sigma).
Enzymic synthesis of NeuNAca2-3Gal,81-3GalNAc and release of sugars from neoglycoproteins Neoglycoprotein containing Gal,/1-3GalNAc was used as an acceptor substrate for o-2,3-sialyltransferase. The reaction mixture contained 10 ,ul of BSA (5 mg/ml), 10 ,ul of 0.5 M sodium cacodylate, pH 6.0, 5 % Triton X-100, 10 ,ul of neoglycoprotein (20 mg/ml), 5 pul of enzyme (200 munits/ml) and 5 pul of CMP-
[I4C]sialic acid (289 mCi/mmol; uCi/400,u). As a positive control for this reaction, asialofetuin was also added in a separate experiment which was performed concurrently. The mixture was incubated at 37 'C overnight and subsequently passed through a fractions (2 ml) were pooled and dialysed against 0.1 % TFA and lyophilized. Samples were redissolved with 1 ml of freshly prepared 0.1 % TFA in a GlycoPrep 1000 reactor vial (Oxford Glycosystems, Oxford, Oxfordshire, U.K.). Automated hydrazinolysis of these samples was subsequently performed in a GlycoPrep 1000 machine using the manufacturer's program for the release of N-and 0-linked sugars from glycoproteins. Each glycan pool was filtered through a 0.22,um poly(tetrafluoroethylene) filter, taken to dryness by rotary evaporation with the temperature maintained at less than 30°C, rinsed with 1 ml of water and finally dissolved in 500,l of water. A small portion (5 ll) was measured for radioactivity and the remaining samples were analysed by weak anion-exchange h.p.l.c. on a Vydac 301PLX575 column (Hichrom, Reading, Berks., U.K.). Gradient conditions were as follows (solvent A was 0.5 M ammonium acetate, pH 5.3, and solvent B was water): initial conditions of 1000% solvent B were maintained for 5 min, then a concave gradient (Waters curve number 7) from 0 to 80 % solvent A was applied over 45 min, followed by a linear gradient from 80 to 100 % solvent A over 5 min. The flow rate was 1 ml/min and 0.5 ml fractions were collected; sample was detected by liquidscintillation counting of the entire set of fractions. In contrast, neoglycoprotein containing
Manal-6(Manoxl-3)(Xylfl-2)Man,81-4GlcNAc,/1-4(Fucal-3)GlcNAc was subjected to manual hydrazinolysis as previously described (Ashford et al., 1987) . Briefly, the conjugated oligosaccharides were released from salt-free and cryogenically dried neoglycoprotein (0.5-1 mg) by treatment with anhydrous hydrazine, re-N-acetylated and reduced with NaB[3H]4 (370 GBq/mmol) from DuPont (Stevenage, Herts., U.K.). The released radiolabelled sugar was analysed by Bio-Gel P4 gel chromatography as previously described (Ashford et al., 1987) . Localization of the alkylated site on BSA It was necessary to add a radiolabelled monosaccharide to facilitate the detection of the synthetic glycosylation site on BSA. Galactosyltransferase was used to incorporate '4C-labelled galactose residues into chitotriose conjugated to BSA. After the transferase reaction, the neoglycoprotein was purified by reversed-phase h.p.l.c. As shown in Figure 2 2b). Radioactive fractions were analysed by the PicoTag method and l.d.m.s. before amino acid sequencing. The ratio of CMcysteine to glucosamine was 1: 3 as expected from the alkylation of one cysteine residue with chitotriose which contains three Nacetylglucosamine residues. However, l.d.m.s. analysis has indicated that several peptides are co-eluted with the putative neoglycopeptide (results not shown). Therefore this sample was further purified by high-resolution microbore h.p.l.c. (Figure 2c ). Only a single radiolabelled peak (peak 8) was resolved and subjected to amino acid sequencing. The amino acid sequence
RESULTS

Formation
which corresponds exactly to a tryptic fragment of BSA from Gly-45 to Lys-65 with the exception of the single non-disulphidelinked cysteine residue at position 58. Attachment of chitotriose to this cysteine residue resulted in a glycosylated cysteine residue (X) which could not be identified by the amino acid sequencer. In contrast, unconjugated cysteine in another tryptic peptide 3)(Xyl,f1-2)Manf1-4GlcNAc,f1-4(Fuca-1-3)GlcNAc] used for neoglycoprotein formation. The difference of 0.5 glucose unit between reduced and non-reduced sugars on Bio-Gel P4 gelpermeation chromatograms is always observed. The minor peak (30 % of total radioactivity) has a hydrodynamic volume of 5.8.
Enzymic sialylation of neoglycoprotein A common 0-linked disaccharide (Gal/l-3GalNAc) was coupled to cysteine residues of fully reduced BSA (18 sugars per BSA molecule) using its iodoacetamide derivative. Peanut agglutinin, a lectin with Galfll-3GalNAc specificity, was found to bind strongly to this neoglycoprotein, whereas Maackia amurensis lectin and Elderberry bark lectin with sugar specificities for a2-3-and a,2-6-linked sialic acids respectively did not (Figure 4 ). This demonstrates that the integrity of the disaccharide remained intact after its derivatization and conjugation to BSA. This neoglycoprotein was tested as an acceptor substrate for a-2,3-sialyltransferase using CMP-N-acetylneuraminic acid as donor. Figure 5a ) which is known to contain mono-to tetra-sialylated structures (Spiro and Bhoyroo, 1974; Green et al., 1988) .
DISCUSSION
In this study we have investigated the use of bromo-and iodoacetamide derivatives of oligosaccharides as alkylating reagents for the production of neoglycopeptides and neoglycoproteins (Scheme 1). The advantages of this method are: (1) the alkylation of protein thiols using iodoacetamide derivatives in aqueous buffers is simple and effective; (2) the attachment of iodoacetamide derivatives is selective to cysteine residues; (3) the resultant thioether linkage does not appear to change the conformation of the sugar (Davis and Flitsch, 1991) ; (4) thioethers are stable and have not been shown to be immunogenic or antigenic (Robey and Fields, 1989) . The present results indicate that bromo-and iodo-acetamide derivatives of oligosaccharides are readily formed from their ,-glycosylamines and these derivatives are reactive and can be selectively coupled to cysteinecontaining peptides (Figure 1 ) and proteins. Thiol-specific glycosylation of proteins by N-(/-saccharide) iodoacetamides was investigated using BSA. The attachment of chitotriose iodoacetamide derivative to the single free cysteine residue (Cys-58) in non-reduced BSA was demonstrated conclusively by amino acid sequencing of the putative neoglycopeptide purified from its tryptic digest (Figure 2 ). This method of conjugating a defined oligosaccharide to cysteine side chains on a protein provides a finer-tuned strategy for synthetic glycosylation of proteins than conventional conjugation methods that utilize e-amino functions of lysine residues, as the number of non-disulphide-linked cysteine residues in proteins is often far fewer than lysine residues. Also modification of cysteines should not alter significantly the net charge on proteins. In principle, it should be possible to replace natural Nlinked glycosylation sites with synthetic cysteine-linked ones in recombinant proteins, thus enabling the synthesis of defined glycoforms of a glycoprotein for functional studies. There is as yet no simple biological or chemical means of obtaining glycoproteins with homogeneous carbohydrate structures attached.
Neoglycoproteins formed using this method can be used in lectin-and antibody-binding assays as shown by the specific binding of an anti-(HRP carbohydrate) monoclonal antibody (YZ1/2.23) and peanut agglutinin to neoglycoproteins presenting HRP oligosaccharides and Gal,/1-3GalNAc (Figures 3a and 4 respectively). This demonstrates that the integrity of the saccharide moieties has not been altered by the derivatization or coupling procedures. Multiple presentation of glycans in neoglycoproteins is advantageous in that affinity to sugar-binding proteins is often increased with multivalency. Neoglycoproteins produced by this method usually contain 15-21 oligosaccharide residues per BSA molecule. Not all 35 cysteine residues on fully reduced BSA were alkylated in the presence of excess N-(Cfsaccharide) iodoacetamide derivatives, which suggests that disulphide formation was occurring during the reaction. It may be possible to alkylate serum albumin fully in an oxygen-free atmosphere, although this was not further investigated.
Synthetic cysteine linkage mimics natural N-linkage as it is equivalent to N-linkage that is extended by an extra CH2-S group. Importantly we have shown that cysteine-linked oligosaccharides can be released from two neoglycoproteins. To our knowledge there is currently no scheme for the release of unprotected sugars from neoglycoproteins. Hydrazinolysis of the neoglycoproteins containing the major HRP oligosaccharide unexpectedly yielded two oligosaccharides. The major HRP glucose units which corresponds to peak A in Figure 3b . The oligosaccharide with hydrodynamic volume of 5.8 glucose units (Figure 3b, peak B) was not identified, but may be the result of the loss of the core fucose and N-acetylglucosamine residues from the 8.8 glucose unit structure which would reduce its hydrodynamic volume to 5.8 glucose units. This result indicates that these sugars retained their reducing ends on cleavage from neoglycoproteins, and suggests a test to determine the stability of certain oligosaccharide structures to hydrazinolysis. Similarly radiolabelled glycans from transferase-treated asialofetuin and neoglycoprotein containing Galfll-3GalNAc were recovered after automated hydrazinolysis. The conditions for maximum release were not determined as the amount of each released glycan was more than sufficient for analysis by weak anionexchange h.p.l.c. The released glycans have similar elution times to those of monosialylated sugars from fetuin on a weak anionexchange column ( Figure 5 ). In the case of the neoglycoprotein containing Galfl1-3GalNAc, enzymic transfer of sialic acid created NeuNAca2-3Gal,fl-3GalNAc on BSA. This suggests the possibility of using this type of linkage in solid-phase enzymic oligosaccharide synthesis schemes.
In summary this study has illustrated the general use of N-(./-saccharide) iodoacetamides for conjugating sugars to cysteinyl side chains of peptides and proteins. Our results demonstrate its usefulness in applications such as site-specific glycosylation and solid-phase enzymic oligosaccharide synthesis.
